PetVivo Holdings (PETV) Research & Development (2010 - 2026)
PetVivo Holdings (PETV) reported Research & Development of $233,419 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 31.5% from $340,513 a year earlier and down 52.4% from the prior quarter.
PetVivo Holdings (PETV) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PetVivo Holdings' Research & Development came in at $1.31 million, down 14.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.42 million, down 10.6% from FY2025.
- Research & Development has a five-year compound annual growth rate of 70.5% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $1.58 million in FY2025 (+13.5%), $1.4 million in FY2024 (+40.0%), $996,358 in FY2023 (+109.8%) and $474,881 in FY2022 (+383.4%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Research & Development since fiscal Q2 2023.
- Year over year, Research & Development gained in three of the last eight quarters, with an average decline of 4.6%.
- The high point for year-over-year Research & Development in five years was fiscal Q3 2023 (growth of 622.9%); the low point was fiscal Q1 2023 (a decline of 47.7%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $490,095 (Q4 2026), $322,991 (Q3 2026) and $261,433 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.19 Bn | 1,108.77 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 634.59 Bn | 554.45 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 499.62 Bn | 472.73 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 354.90 Bn | 309.28 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 300.00 Bn | 263.99 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 263.32 Bn | 237.01 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 238.09 Bn | 193.49 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.99 Bn | 168.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.34 Bn | 116.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | PetVivo Holdings | 25.47 Mn | 24.21 Mn | 223,317.00 | 233,419.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 233,419.00 |
| Mar 31, 2026 | 490,095.00 |
| Dec 31, 2025 | 322,991.00 |
| Sep 30, 2025 | 261,433.00 |
| Jun 30, 2025 | 340,513.00 |
| Mar 31, 2025 | 358,608.00 |
| Dec 31, 2024 | 371,953.00 |
| Sep 30, 2024 | 465,174.00 |
| Jun 30, 2024 | 387,515.00 |
| Mar 31, 2024 | 390,591.00 |
| Dec 31, 2023 | 351,584.00 |
| Sep 30, 2023 | 359,332.00 |
| Jun 30, 2023 | 293,772.00 |
| Mar 31, 2023 | 536,161.00 |
| Dec 31, 2022 | 248,157.00 |
| Sep 30, 2022 | 140,384.00 |
| Jun 30, 2022 | 71,656.00 |
| Mar 31, 2022 | 187,238.00 |
| Dec 31, 2021 | 34,326.00 |
| Sep 30, 2021 | 116,380.00 |
PetVivo Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PETV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PETV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PETV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();